[Oral lichen planus (OLP). Therapeutic guidelines and clinical experience with 71 patients].
The authors report the results of a study performed in 71 patients suffering from lichen planus of the mucous membranes and skin. They discuss dermatological and stomatological clinical data in relation to possible basal diseases (hepatopathies, dermopathies, diabetes, hypertension, gastrointestinal diseases, etc.) and other anamnestic data (psychological aspects, drug taking, working activity, etc.). Moreover, they report the results of the clinical protocol used (betamethasone in a gel and vitamin A base) with a follow-up of 5 years and examine the other therapeutic possibilities reported in the literature.
Vescovi
P
P
Istituto di Clinica Odontoiatrica, Università degli Studi, Parma.
Gennari
P U
PU
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005782:Gels; D005938:Glucocorticoids; D006801:Humans; D017676:Lichen Planus, Oral / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D014801:Vitamin A / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D005782:Gels; D005938:Glucocorticoids; D014801:Vitamin A; D001623:Betamethasone